Shandong Luning Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Shandong Luning Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 7 active records with this name as holder; 6 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
10 acceptance records as first applicant, grouped into 7 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Dapagliflozin Tablets 2 records · Latest accepted 2025/12/24
Generic · 2
Thioctic Acid Tablets 2 records · Latest accepted 2024/11/14
Generic · 2
Empagliflozin Tablets 2 records · Latest accepted 2024/08/09
Generic · 2
Mecobalamin Tablets 1 records · Latest accepted 2024/02/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400593 | Generic | 2024/02/08 | Shandong Luning Pharmaceutical Co., Ltd. | CDE ↗ |
LN020干混悬剂 · No verified English name 1 records · Latest accepted 2023/06/14
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300641 | New drug | 2023/06/14 | Shandong Luning Pharmaceutical Co., Ltd. | CDE ↗ |
Alogliptin Benzoate Tablets 1 records · Latest accepted 2023/04/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301029 | Generic | 2023/04/12 | Shandong Luning Pharmaceutical Co., Ltd. | CDE ↗ |
Tadalafil Tablets 1 records · Latest accepted 2021/03/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101019 | Generic | 2021/03/12 | Shandong Luning Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
Under review
2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Dapagliflozin Tablets | CYHS2504366 | Generic | 2025/12/24 | Shandong Luning Pharmaceutical Co., Ltd. | CDE ↗ |
| Dapagliflozin Tablets | CYHS2504365 | Generic | 2025/12/24 | Shandong Luning Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
7 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Thioctic Acid Tablets | Shandong Luning Pharmaceutical Co., Ltd. | Shandong Luning Pharmaceutical Co., Ltd. | 国药准字H20264731 | 2026/06/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Thioctic Acid Tablets | Shandong Luning Pharmaceutical Co., Ltd. | Shandong Luning Pharmaceutical Co., Ltd. | 国药准字H20264732 | 2026/06/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Empagliflozin Tablets | Shandong Luning Pharmaceutical Co., Ltd. | Shandong Luning Pharmaceutical Co., Ltd. | 国药准字H20256043 | 2025/11/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Empagliflozin Tablets | Shandong Luning Pharmaceutical Co., Ltd. | Shandong Luning Pharmaceutical Co., Ltd. | 国药准字H20256044 | 2025/11/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mecobalamin Tablets | Shandong Luning Pharmaceutical Co., Ltd. | Shandong Luning Pharmaceutical Co., Ltd. | 国药准字H20255119 | 2025/08/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alogliptin Benzoate Tablets | Shandong Luning Pharmaceutical Co., Ltd. | Shandong Luning Pharmaceutical Co., Ltd. | 国药准字H20244511 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tadalafil Tablets | Shandong Luning Pharmaceutical Co., Ltd. | Shandong Luning Pharmaceutical Co., Ltd. | 国药准字H20233017 | 2023/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
6 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 阿戈美拉汀 · No verified English name | Shandong Luning Pharmaceutical Co., Ltd. | Y20240000426 | A | 2026/05/12 | CDE ↗ |
| 硫辛酸 · No verified English name | Shandong Luning Pharmaceutical Co., Ltd. | Y20230000541 | A | 2026/02/07 | CDE ↗ |
| 他达拉非等2个品种 · No verified English name | Shandong Luning Pharmaceutical Co., Ltd. | Y20210000671 | A | 2025/10/12 | CDE ↗ |
| 阿齐沙坦 · No verified English name | Shandong Luning Pharmaceutical Co., Ltd. | Y20200000611 | A | 2025/12/08 | CDE ↗ |
| 苯甲酸阿格列汀 · No verified English name | Shandong Luning Pharmaceutical Co., Ltd. | Y20200000540 | A | 2026/10/23 | CDE ↗ |
| 酮洛芬 · No verified English name | Shandong Luning Pharmaceutical Co., Ltd. | Y20260000881 | I | 2026/11/12 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.